Tuesday, March 05, 2024 8:39:29 AM
——
Form PRE 14A - Other preliminary proxy statements
Recent JAGX News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/13/2026 08:59:50 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts • ACCESS Newswire • 03/11/2026 01:00:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 01:05:16 PM
- Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants • ACCESS Newswire • 03/09/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 02:05:51 PM
- Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 • ACCESS Newswire • 03/03/2026 02:00:00 PM
- Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend • ACCESS Newswire • 03/02/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 02:01:37 PM
- Jaguar Health Announces a Special One-time Stock Dividend • ACCESS Newswire • 02/18/2026 02:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 07:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 09:15:29 PM
- Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi • ACCESS Newswire • 01/22/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:05:24 PM
- Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts • ACCESS Newswire • 01/14/2026 02:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/12/2026 06:05:58 PM
- Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million • ACCESS Newswire • 01/12/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 11:04:18 AM
- Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication • ACCESS Newswire • 01/06/2026 02:00:00 PM
- Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs • ACCESS Newswire • 01/02/2026 02:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
